Health Net Receivables from 2010 to 2026
| HCAT Stock | USD 2.15 0.01 0.46% |
Net Receivables | First Reported 2018-03-31 | Previous Quarter 68.4 M | Current Value 60.1 M | Quarterly Volatility 14.2 M |
Check Health Catalyst financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Health Catalyst's main balance sheet or income statement drivers, such as Tax Provision of 314.7 K, Net Interest Income of 1.1 M or Interest Income of 21.7 M, as well as many indicators such as Price To Sales Ratio of 1.52, Dividend Yield of 0.0 or PTB Ratio of 0.99. Health financial statements analysis is a perfect complement when working with Health Catalyst Valuation or Volatility modules.
Health | Net Receivables | Build AI portfolio with Health Stock |
The evolution of Net Receivables for Health Catalyst provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Health Catalyst compares to historical norms and industry peers.
Latest Health Catalyst's Net Receivables Growth Pattern
Below is the plot of the Net Receivables of Health Catalyst over the last few years. It is Health Catalyst's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Health Catalyst's overall financial position and show how it may be relating to other accounts over time.
| Net Receivables | 10 Years Trend |
|
Net Receivables |
| Timeline |
Health Net Receivables Regression Statistics
| Arithmetic Mean | 33,295,957 | |
| Geometric Mean | 28,798,138 | |
| Coefficient Of Variation | 55.03 | |
| Mean Deviation | 16,619,950 | |
| Median | 27,570,000 | |
| Standard Deviation | 18,321,993 | |
| Sample Variance | 335.7T | |
| Range | 48.7M | |
| R-Value | 0.89 | |
| Mean Square Error | 72.6T | |
| R-Squared | 0.80 | |
| Slope | 3,239,554 | |
| Total Sum of Squares | 5371.1T |
Health Net Receivables History
About Health Catalyst Financial Statements
Health Catalyst shareholders use historical fundamental indicators, such as Net Receivables, to determine how well the company is positioned to perform in the future. Although Health Catalyst investors may analyze each financial statement separately, they are all interrelated. The changes in Health Catalyst's assets and liabilities, for example, are also reflected in the revenues and expenses on on Health Catalyst's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Receivables | 65.8 M | 46 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Health Stock Analysis
When running Health Catalyst's price analysis, check to measure Health Catalyst's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health Catalyst is operating at the current time. Most of Health Catalyst's value examination focuses on studying past and present price action to predict the probability of Health Catalyst's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health Catalyst's price. Additionally, you may evaluate how the addition of Health Catalyst to your portfolios can decrease your overall portfolio volatility.